UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Understanding when credit card rewards are taxed is essential for effective financial planning. Discover the rules that apply to you.
8,648 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Pi Network announces a major protocol upgrade and an AI-focused case study, setting the stage for potential moves aro...
Investors chase the next big AI champion. This piece breaks down how a single AI stock could grow into a trillion-dol...
As Alphabet shifts its advertising footprint and data strategy, Disney investors just really need to understand the p...
In the fast-moving world of micro-scale tech, rapid micro (rpid) earnings calls can signal whether a company is susta...
Philip Morris International and British American Tobacco report 2025 results, revealing divergent paths in smoke-free...
Defense markets are shifting as missiles that changed balance drive bigger budgets and stronger stock moves. This rep...
Two leading prediction-market platforms are pursuing high-value fundraising as U.S. lawmakers eye tighter rules. Iran...
Small-cap value ETFs can add ballast and growth potential to a portfolio. This guide compares ISCV and IWN, highlight...
As Abeona prepares to report 2025 results, investors need a clear framework to interpret the numbers. This guide brea...
Lucid has fallen sharply, dropping more than half in the last year. This article breaks down why the stock’s slump ha...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...